|
Wednesday, 21 February 2018, 08:25 HKT/SGT | |
| | | | Source: Eisai | |
|
|
TOKYO, Feb 21, 2018 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has been certified in 2018 as an Outstanding Health and Productivity Management Organization in the large enterprise category (White 500) by Japan's Ministry of Economy, Trade and Industry, who organizes the Certified Health and Productivity Management Organization Recognition Program in cooperation with Nippon Kenko Kaigi which consists of leaders of medical care associations, economic associations as well as municipalities.
Under the recognition program, the Nippon Kenko Kaigi examines large enterprises, small-medium enterprises and other organizations engaging in initiatives for overcoming health-related challenges in regional communities or for promoting health-conscious activities led by the Nippon Kenko Kaigi, and recognizes outstanding enterprises engaging in efforts for health and productivity management. The five criteria for selection in the recognition program for the large enterprise category are (i) the positioning of health and productivity management in management philosophy and policies, (ii) organized frameworks established for tackling health and productivity management, (iii) specific systems established for ensuring health-conscious management as well as measures introduced for implementing them, (iv) measures established for assessing and improving health and productivity management, and (v) adherence to laws and regulations and risk management. This is the second year of the recognition program, and 541 companies were recognized as Outstanding Health and Productivity Management Organizations in the large enterprise category (White 500), along with 775 companies in the small-medium enterprise category.
Eisai's corporate philosophy is to give first thought to patients and their families and increase the benefits that health care provides as well as address diverse healthcare needs worldwide. The maintenance and promotion of the health of employees, who are key stakeholders in the company, is an important element in actualizing this corporate philosophy, and Eisai will continue to foster initiatives for the implementation of health management in the future as well.
Contact:
Public Relations Department,
Eisai Co., Ltd.
+81-3-3817-5120
Topic: Press release summary
Source: Eisai
Sectors: BioTech, Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
Eisai |
Apr 1, 2025 12:15 HKT/SGT |
Eisai to Divest Rights for Pariet in China to Peak Pharma |
Mar 25, 2025 16:28 HKT/SGT |
World's First Early Alzheimer's Disease Treatment Developed in Japan LEQEMBI Receives Prime Minister's Award at the 12th Technology Management and Innovation Awards |
Mar 25, 2025 11:21 HKT/SGT |
Eisai Selected as a Nadeshiko Brand 2025 as a Listed Company Excelling in Promotion of Women in the Workplace |
Mar 10, 2025 19:24 HKT/SGT |
Eisai Recognized as "2025 Kenko Investment for Health" for the First Time and Certified as "Outstanding Organization Of Kenko Investment for Health Program (White 500)" for the Sixth Time |
Mar 5, 2025 08:09 HKT/SGT |
Eisai: Update on the Co-Promotion of the Oral Antifungal Agent Nailin Capsules 100mg in Japan |
Mar 4, 2025 16:22 HKT/SGT |
Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer's Disease in Australia |
Mar 3, 2025 14:41 HKT/SGT |
"Fatigue Recovery While You Sleep!" Eisai to Launch Designated Quasi-Drug Drink "Chocola BB Nightwell" |
Mar 3, 2025 12:53 HKT/SGT |
The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease |
Feb 28, 2025 11:31 HKT/SGT |
Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Factor (FGF) Receptor Selective Tyrosine Kinase Inhibitor Tasurgratinib in Greater China Region (Mainland China, Hong Kong, Macau, and Taiwan) with SciClone |
Feb 20, 2025 12:29 HKT/SGT |
Eisai Selected for "Human Capital Leaders 2024" and "Human Capital Management Gold Quality" for Second Consecutive Year, as a Company Committed to Excellent Management and Disclosure of Human Capital Initiatives |
More news >> |
 |
|
 |
|